GLORIA

GEOMAR Library Ocean Research Information Access

X

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    Experiences of menopause during incarceration
    Ovid Technologies (Wolters Kluwer Health) ; 2021
    In:  Menopause Vol. 28, No. 7 ( 2021-03-11), p. 829-832
    Details
    In: Menopause, Ovid Technologies (Wolters Kluwer Health), Vol. 28, No. 7 ( 2021-03-11), p. 829-832
    Abstract: Despite increasing representation of older women in US jail and prison facilities, their menopause experiences and access to related care remain uncharacterized. Our objective is to explore the menopause experiences of women incarcerated in jail and prison facilities. Methods: We conducted a pilot study of four semi-structured in-depth interviews with women in the community who experienced menopause symptoms while incarcerated in either a prison or jail facility. Results: Preliminary findings suggest critical gaps in access to menopause-related resources and medical care. Participants described that lifestyle and medical interventions for menopause in prison were inaccessible, and that untreated symptoms contributed to significant distress. Participants reported feeling as though medical staff did not believe their concerns and were dismissive of their complaints. In some cases, menopause symptoms and symptom management exacerbated the ways in which institutional barriers reproduce criminalization within the carceral system. Conclusions: Individuals going through the menopause transition while experiencing incarceration have significant unmet needs and poor access to relieving lifestyle changes or medical interventions. Policy and practice changes should address menopause-related needs of individuals experiencing incarceration. Video Summary: http://links.lww.com/MENO/A730.
    Type of Medium: Online Resource
    ISSN: 1530-0374
    URL: Article
    DOI: 10.1097/GME.0000000000001762
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2021
    detail.hit.zdb_id: 2071114-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 2
    Online Resource
    Online Resource
    Responsible Care in the Face of Shifting Recommendations and Imperfect Diagnostics for Zika Virus
    American Medical Association (AMA) ; 2017
    In:  JAMA Vol. 318, No. 21 ( 2017-12-05), p. 2075-
    Details
    In: JAMA, American Medical Association (AMA), Vol. 318, No. 21 ( 2017-12-05), p. 2075-
    Type of Medium: Online Resource
    ISSN: 0098-7484
    URL: Article
    DOI: 10.1001/jama.2017.15680
    RVK:
    XA 10000
    Language: English
    Publisher: American Medical Association (AMA)
    Publication Date: 2017
    detail.hit.zdb_id: 2958-0
    detail.hit.zdb_id: 2018410-4
    SSG: 5,21
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 3
    Online Resource
    Online Resource
    Conspiracy theories and misinformation about COVID-19 in Nigeria: Implications for vaccine demand generation communications
    Elsevier BV ; 2022
    In:  Vaccine Vol. 40, No. 13 ( 2022-03), p. 2114-2121
    Details
    In: Vaccine, Elsevier BV, Vol. 40, No. 13 ( 2022-03), p. 2114-2121
    Type of Medium: Online Resource
    ISSN: 0264-410X
    URL: Article
    DOI: 10.1016/j.vaccine.2022.02.005
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2022
    detail.hit.zdb_id: 1468474-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 4
    Online Resource
    Online Resource
    Views among Malawian women about joining HIV prevention clinical trials when pregnant
    Springer Science and Business Media LLC ; 2020
    In:  AIDS Research and Therapy Vol. 17, No. 1 ( 2020-12)
    Details
    In: AIDS Research and Therapy, Springer Science and Business Media LLC, Vol. 17, No. 1 ( 2020-12)
    Abstract: The pressing need to expand the biomedical HIV prevention evidence base during pregnancy is now increasingly recognized. Women’s views regarding participation in such trials and initiating PrEP while pregnant are critical to inform evolving policy and best practices aimed at responsibly expanding evidence-based access for this population. Methods We conducted 35 semi-structured interviews with reproductive-aged women in Malawi in the local language, Chichewa. Participants were HIV-negative and purposively sampled to capture a range of experience with research during pregnancy. Women’s perspectives on enrolling in three hypothetical HIV prevention trial vignettes while pregnant were explored, testing: (1) oral PrEP (Truvada) (2) a vaginal ring (dapivirine), and (3) a randomized trial comparing the two. The vignettes were read aloud to participants and a simple visual was provided. Interviews were audio-recorded, transcribed, translated, and coded using NVivo 11. Thematic analysis informed the analytic approach. Results A majority of women accepted participation in all trials. Women’s views on research participation varied largely based on their assessment of whether participation or nonparticipation would best protect their own health and that of their offspring. Women interested in participating described power dynamics with their partner as fueling their HIV exposure concerns and highlighted health benefits of participation—principally, HIV protection and access to testing/treatment and ancillary care, and perceived potential risks of the vignettes as low. Women who were uninterested in participating highlighted potential maternal and fetal health risks of the trial, challenges of justifying prevention use to their partner, and raised some modality-specific concerns. Women also described ways their social networks, sense of altruism and adherence requirements would influence participation decisions. Conclusions The majority of participants conveyed strong interest in participating in biomedical HIV prevention research during pregnancy, largely motivated by a desire to protect themselves and their offspring. Our results are consistent with other studies that found high acceptance of HIV prevention products during pregnancy, and support the current direction of HIV research policies and practices that are increasingly aimed at protecting the health of pregnant women and their offspring through responsible research, rather than defaulting to their exclusion.
    Type of Medium: Online Resource
    ISSN: 1742-6405
    URL: Article
    DOI: 10.1186/s12981-020-00271-6
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2020
    detail.hit.zdb_id: 2173450-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 5
    Online Resource
    Online Resource
    Rubella Vaccine—Reply
    American Medical Association (AMA) ; 2018
    In:  JAMA Pediatrics Vol. 172, No. 1 ( 2018-01-01), p. 96-
    Details
    In: JAMA Pediatrics, American Medical Association (AMA), Vol. 172, No. 1 ( 2018-01-01), p. 96-
    Type of Medium: Online Resource
    ISSN: 2168-6203
    URL: Article
    DOI: 10.1001/jamapediatrics.2017.4154
    Language: English
    Publisher: American Medical Association (AMA)
    Publication Date: 2018
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 6
    Online Resource
    Online Resource
    Menopause-related medication use among women age 45-75 experiencing incarceration in North Carolina 2015-2016
    Emerald ; 2022
    In:  International Journal of Prisoner Health Vol. 18, No. 2 ( 2022-06-02), p. 176-184
    Details
    In: International Journal of Prisoner Health, Emerald, Vol. 18, No. 2 ( 2022-06-02), p. 176-184
    Abstract: This study aims to estimate the prevalence of individuals receiving hormone therapy for menopause management and the prevalence of underlying conditions that may constrain options for pharmacologic menopause management in the prison context. Design/methodology/approach This study reviewed all prescriptions dispensed by the North Carolina Department of Public Safety between July 1, 2015, and June 30, 2016, for relevance to menopause management. Relevant medications were those either recommended for menopause management or those indicated for management of conditions that may complicate menopause management, as per the 2015 clinical decision-support algorithm tool developed by the North American Menopause Society. Analysis was restricted to women between the ages of 45 and 75. Findings Of 1,120 women, a majority (77.8%) were between the ages of 45 and 54. Less than 5% of individuals in this study were prescribed estrogen-containing therapy. The most commonly prescribed medications that may constrain options for menopause treatment were related to hypertension and other cardiovascular disease or mental health conditions. Research limitations/implications The retrospective nature of this data set limits the findings, given that researchers did not have access to diagnoses or data on polypharmacy. Still, this study indicates that many women over 45 experiencing incarceration are living with health conditions that may complicate menopause symptom management with hormone therapy. Future research in carceral settings must examine the prevalence of menopause-related symptoms as well as access to and quality of comprehensive menopause management. Originality/value There is a paucity of literature around the menopause-related needs of individuals experiencing incarceration. To the best of the authors’ knowledge, no other research has examined prevalence of pharmacologic menopause management among women who are incarcerated.
    Type of Medium: Online Resource
    ISSN: 1744-9200 , 1744-9200
    URL: Article
    DOI: 10.1108/IJPH-07-2021-0068
    Language: English
    Publisher: Emerald
    Publication Date: 2022
    detail.hit.zdb_id: 2220160-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 7
    Online Resource
    Online Resource
    Establishing Better Evidence on Remote Monitoring for Postpartum Hypertension: A Silver Lining of the Coronavirus Pandemic
    Georg Thieme Verlag KG ; 2020
    In:  American Journal of Perinatology Reports Vol. 10, No. 03 ( 2020-07), p. e315-e318
    Details
    In: American Journal of Perinatology Reports, Georg Thieme Verlag KG, Vol. 10, No. 03 ( 2020-07), p. e315-e318
    Abstract: The transformation of our health care system in response to coronavirus disease 2019 (COVID-19) provides a unique opportunity to examine the use of telehealth for postpartum care. The postpartum period can pose significant risks and challenges, particularly for women with hypertensive disorders of pregnancy. Remote blood pressure monitoring has proven feasible and acceptable among women and providers but has not been widely implemented or researched. Early studies have identified improved outcomes with use of telehealth, including increased compliance with care and decreased disparity in hypertension follow-up. Preliminary data make a compelling case for remote monitoring as a promising treatment strategy to manage postpartum hypertension. Remote monitoring technology should be incorporated as a standard component for the comprehensive management of postpartum hypertension during COVID-19. As a consequence of the pandemic, we now have an opportunity to research the impact of postpartum remote blood pressure monitoring on maternal outcome and disparities within these outcomes.
    Type of Medium: Online Resource
    ISSN: 2157-6998 , 2157-7005
    URL: Article
    DOI: 10.1055/s-0040-1715169
    Language: English
    Publisher: Georg Thieme Verlag KG
    Publication Date: 2020
    detail.hit.zdb_id: 2628594-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 8
    Online Resource
    Online Resource
    Pregnant Individuals' Views on Fetal Tissue Research in the United States
    Ovid Technologies (Wolters Kluwer Health) ; 2021
    In:  Obstetrics & Gynecology Vol. 138, No. 5 ( 2021-11), p. 755-761
    Details
    In: Obstetrics & Gynecology, Ovid Technologies (Wolters Kluwer Health), Vol. 138, No. 5 ( 2021-11), p. 755-761
    Abstract: Fetal tissue research has driven significant medical advances but remains publicly contentious in the United States. The views of pregnant individuals in the United States regarding the donation of fetal tissue offer an important and previously unexplored perspective on this issue. METHODS: We conducted a secondary analysis of data from two separate, broader qualitative studies. Pregnant and recently pregnant individuals (N=79) from clinical sites at the University of North Carolina at Chapel Hill, Johns Hopkins University, and Massachusetts General Hospital were interviewed individually using a semi-structured guide addressing a range of issues related to infectious disease research and pregnancy, including the acceptability of fetal tissue research. Interviews were transcribed, coded, and analyzed for emergent themes. RESULTS: Among this sample of predominantly Black (61%), reproductive-aged pregnant and recently pregnant participants, the majority (72%) generally supported fetal tissue research. The following three themes were identified: choice, respect, and meaning. Respondents discussed the deeply personal nature of decisions surrounding fetal tissue research, emphasizing the importance of informed consent and respect for the person's emotional state when approaching for consent. The ways in which participants regarded how to respectfully handle fetal tissue also shaped views about the acceptability of donation, both for and against. For many participants, fetal tissue donation to research represented one way of ascribing meaning to pregnancy termination or loss. CONCLUSION: Among this diverse sample of pregnant and recently pregnant individuals, most were supportive of fetal tissue donation for research. A better understanding of pregnant individuals' views on this topic may lead to policies and practices that are congruent with the needs and values of people facing decisions regarding the disposition of fetal remains.
    Type of Medium: Online Resource
    ISSN: 0029-7844
    URL: Article
    DOI: 10.1097/AOG.0000000000004576
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2021
    detail.hit.zdb_id: 2012791-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 9
    Online Resource
    Online Resource
    Pregnant Women's Attitudes Toward Zika Virus Vaccine Study Participation [8J]
    Ovid Technologies (Wolters Kluwer Health) ; 2018
    In:  Obstetrics & Gynecology Vol. 131, No. 1 ( 2018-05), p. 110S-110S
    Details
    In: Obstetrics & Gynecology, Ovid Technologies (Wolters Kluwer Health), Vol. 131, No. 1 ( 2018-05), p. 110S-110S
    Abstract: Preventing Zika Virus (ZIKV) infection by vaccinating women may decrease risk of congenital Zika syndrome. Clinical trials are underway for inactivated, live attenuated, and DNA ZIKV vaccines. We sought to describe pregnant women’s attitudes toward participation in ZIKV vaccine research involving different vaccine platforms and to identify participation predictors and barriers. METHODS: Women attending prenatal care in June and July 2017 were offered enrollment in an anonymous survey which asked women their views about participating in hypothetical ZIKV vaccine research scenarios during pregnancy. Demographics and Zika exposure during pregnancy were obtained. RESULTS: Of 129 women, 70% expressed concern about ZIKV infection during pregnancy and 44% changed travel plans. Given the study scenarios, 68% stated they would consider an inactivated vaccine trial compared to 19% willing to participate in a live attenuated vaccine trial (p-value 〈 0.0001). DNA vaccine trial acceptance was 51.6%. 57% of women believed the inactivated vaccine during pregnancy was safe for their baby compared to 26% for a live attenuated (p-value 0.012). Willing trial participants were most motivated by a desire to protect their babies from ZIKV, fewer were strongly motivated by a desire to contribute to science. CONCLUSION: Inclusion of pregnant women in ZIKV vaccine trials is imperative to ensure vaccines are safe, effective, and acceptable in pregnancy. A majority of women in our cohort would accept participation in inactivated and DNA vaccine trials during pregnancy while fewer would participate in a trial of a live attenuated vaccine. Understanding women’s motivations for trial participation is critical to vaccine trial design.
    Type of Medium: Online Resource
    ISSN: 0029-7844
    URL: Article
    DOI: 10.1097/01.AOG.0000533473.70546.80
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2018
    detail.hit.zdb_id: 2012791-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 10
    Online Resource
    Online Resource
    Prioritization of pregnant individuals in state plans for coronavirus disease 2019 vaccination
    Elsevier BV ; 2021
    In:  American Journal of Obstetrics and Gynecology Vol. 225, No. 1 ( 2021-07), p. 95-99
    Details
    In: American Journal of Obstetrics and Gynecology, Elsevier BV, Vol. 225, No. 1 ( 2021-07), p. 95-99
    Type of Medium: Online Resource
    ISSN: 0002-9378
    URL: Article
    DOI: 10.1016/j.ajog.2021.03.015
    RVK:
    XA 19400
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2021
    detail.hit.zdb_id: 2003357-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...